MedTrace Logo

Prevalence of Inappropriate Prescriptions and Omitted Therapies in Hospitalized Elderly: STOPP/START Criteria Analysis

NCT07202962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-10-02

No results posted yet for this study

Summary

Evaluate the prevalence of potentially inappropriate prescriptions (PIPs) and potential omitted prescriptions (PPOs) in elderly patient upon admission to the acute geriatric department, based on adherence or non-adherence to the recommendations specified in STOPP and START criteria.

Conditions

  • Polypharmacy (People Under Treatment With 5 or More Drugs)
  • Elderly (People Aged 65 or More)
  • Deprescribing
  • Hospitalization

Interventions

DRUG

medication review and deprescribing

The study protocol includes the following assessments: * T0: first data collection upon admission to the ward; * T1 assessment: pharmacological review at discharge. Subjects who meet all study eligibility criteria will come consecutively enrolled in the study during admission to the department (T0). By consulting the electronic health record, interviewing patients and family members and personal documentation, the following data will be collected: * Remote and immediate pathological history; * Family and social history; * Home therapy; * BRIEF-MPI. Home therapy and therapy suggested at discharge will be compared with the STOPPandSTART criteria to evaluate the prevalence of potential therapies inappropriate and to study possible interactions and contraindications pharmacological and for reporting possible adverse reactions to drugs. The prevalence and possible prevalence of each individual STOPPandSTART criterion will be assessed association with other variables of interest.

Sponsors & Collaborators

  • Regione del Veneto - AULSS n. 7 Pedemontana

    lead OTHER

Principal Investigators

  • Luca Pellizzari Dr. Pellizzari, DR · Regione del Veneto - AULSS n. 7 Pedemontana

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-17
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07202962 on ClinicalTrials.gov